Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients (RADIOMICS - OHCM)

NCT07695272 is registered in ClinicalTrials.gov with Centro Cardiologico Monzino as lead sponsor.

NCT NCT07695272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients (RADIOMICS - OHCM)
Lead sponsor
Centro Cardiologico Monzino
Phase
Observational
Overall status
Active, not recruiting
Start date
June 1, 2026
Completion date
June 1, 2031
Enrollment
2,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac myosin inhibitors, hypertrophic cardiomyopathy (hcm)